Quick Takeaways
- Claire Fraser has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,360,515.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Claire Fraser
- Location
- Milford, MA
- Summary
- The estimated net worth of Claire Fraser is at least $4,360,515 dollars as of 27 Feb 2026. Claire Fraser is the Director of BECTON DICKINSON & CO and owns shares of BECTON DICKINSON & CO (BDX) stock worth about $4.17M. Claire Fraser is the Director of WATERS CORP /DE/ and owns shares of WATERS CORP /DE/ (WAT) stock worth about $193.1K.
- Signature
- /s/ Michael Lynn, attorney-in-fact for Claire Fraser
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Claire Fraser and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BECTON DICKINSON & CO ($4,167,375).
- Past-year value change for that position: -$337,892.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Claire Fraser
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BDX | BECTON DICKINSON & CO | Director | $4,167,375 | -$337,892 | -7.5% | 10 Sep 2025 |
| WAT | WATERS CORP /DE/ | Director | $193,140 | 25 Feb 2026 | ||
| MCRB | Seres Therapeutics, Inc. | Director | 01 Jul 2025 |
Insider Transactions Reported by Claire Fraser:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.